NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE
Abstract
NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE AND STUDY THE SHELF-LIFE.
Key facts
- NIH application ID
- 10710314
- Project number
- 75N98019D00058-0-759102200003-1
- Recipient
- IRISYS, INC.
- Principal Investigator
- ROBERT GIANNINI
- Activity code
- N02
- Funding institute
- NIH
- Fiscal year
- 2022
- Award amount
- $639,151
- Award type
- —
- Project period
- 2022-04-11 → 2026-04-10